Joseph Aquilino: Creator
Melissa Sugierski: Marketing and Promotions
Amanda Davidson: Marketing and Promotions
Calmare has successfully treated over 4,000 patients worldwide, where it has been shown to be effective in treating neuropathic and oncologic pain. Conditions treated include:
The device is currently being used in the US at these key teaching hospitals:
The Calmare medical device was developed by Professor Giuseppe Marineo, a researcher and bioengineer and the founder and manager of Delta Research & Development. Delta R&D is the Bioengineering Research Centre affiliated with Tor Vergata University of Rome, Italy.
The device, with a biophysical rather than a biochemical approach, uses a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin. The device creates and sends a no-pain signal which becomes the dominant signal received by the brain, thus overriding the pain signal and providing relief for the patient.
The technology was brought to Competitive Technologies, Inc. (OTCQX: CTTC) through the efforts of Prof. Giancarlo Elia Valori of the Italian business development group, Sviluppo Lazio S.p.A. CTTC licensee GEOMC of Korea is manufacturing the device commercially for worldwide sales.
In honor of the technology's Italian inventor, CTTC chose to call this
medical device "Calmare Pain Therapy Treatment." Translated from the
Italian, "calmare" means "to soothe or ease." Calmare Pain Therapy
Treatment eases the suffering that patients endure from debilitating